CA 15-3

The CA 15-3 blood test measures the circulating MUC1 tumor marker (reported in U/mL) and is offered as a home collection service across Dubai with certified phlebotomists and accredited labs for fast turnaround. It is primarily used to monitor treatment response and detect recurrence in people with a known breast cancer diagnosis, but it is not recommended as a stand‑alone screening or diagnostic test because levels can be elevated in benign conditions and vary by assay (common reference thresholds are around 30 U/mL). No special fasting is usually required for the venous sample; abnormal results should be discussed with your oncologist or treating physician who will interpret CA 15‑3 alongside imaging and clinical findings.

• CA 15-3
• Sample type: Serum
• Assay method: Chemiluminescence immunoassay (CLIA)
• Reference range: ≤30 U/mL (adult females)

• Serum CA 15‑3 blood test for monitoring breast cancer tumor marker levels and detecting recurrence
• Designed for post-treatment surveillance and assessing response to therapy
• Home phlebotomy available across Dubai with certified UAE laboratories
• Fast electronic results, typically delivered within 24–48 hours for clinical follow-up
• Not a standalone diagnostic test—abnormal values require imaging and oncologist consultation

• Home phlebotomy for CA 15-3 tumor marker to monitor breast cancer treatment and surveillance
• Licensed phlebotomists and DHA-accredited laboratories serving all Dubai neighborhoods
• Rapid turnaround with secure e-report and trend comparison to prior CA 15-3 values (typically 24–48 hours)
• Useful for assessing treatment response and early detection of recurrence when used alongside clinical assessment and imaging
• Optional oncology clinician interpretation and follow-up recommendations as an add-on

• Home blood collection by a certified phlebotomist in Dubai for CA 15-3 serum analysis
• Used to monitor breast cancer treatment response and detect recurrence—serves as an adjunct, not a standalone diagnostic
• No special preparation or fasting required; results typically delivered within 24–48 hours
• Test processed in UAE‑certified laboratories with digital reports that can be shared with your oncologist